DDInter451 DDInter1340
Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria, and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-, methyl-, deoxyadenosyl- and hydroxy-cobalamin forms. The _cyano_ form, is the most widely used form in supplements and prescription drugs, [FDA label]. Several pharmaceutical forms of cyanocobalamin have been developed, including the tablet, injection, and nasal spray forms [FDA label],,. This drug was initially approved by the FDA in 1942 [FDA label].
Originally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid. This drug was the first clinical useful drug in its class, and its approval was followed by the formulation of many other proton pump inhibitor drugs . Omeprazole is generally effective and well-tolerated, promoting its popular use in children and adults [FDA label].
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Pantoprazole
Pantoprazole {u} (Compound) resembles {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Esomeprazole
Esomeprazole {u} (Compound) resembles {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Pantoprazole
Pantoprazole {u} (Compound) resembles {v} (Compound) Esomeprazole
Esomeprazole {u} (Compound) resembles {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Esomeprazole
Esomeprazole {u} (Compound) resembles {v} (Compound) Pantoprazole
Pantoprazole {u} (Compound) resembles {v} (Compound) Omeprazole
Cyanocobalamin {u} (Compound) resembles {v} (Compound) Hydroxocobalamin
Hydroxocobalamin {u} (Compound) causes {v} (Side Effect) Agitation
Agitation {u} (Side Effect) is caused by {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Rabeprazole
Rabeprazole {u} (Compound) resembles {v} (Compound) Esomeprazole
Esomeprazole {u} (Compound) resembles {v} (Compound) Omeprazole
Cyanocobalamin {u} (Compound) binds {v} (Gene) MUT
MUT {u} (Gene) is regulated by {v} (Gene) TIPARP
TIPARP {u} (Gene) is upregulated by {v} (Compound) Omeprazole
Cyanocobalamin {u} (Compound) binds {v} (Gene) TCN2
TCN2 {u} (Gene) is associated with {v} (Disease) prostate cancer
prostate cancer {u} (Disease) is palliated by {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Pantoprazole
Pantoprazole {u} (Compound) binds {v} (Gene) CYP1A2
CYP1A2 {u} (Gene) is bound by {v} (Compound) Omeprazole
Cyanocobalamin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Esomeprazole
Esomeprazole {u} (Compound) treats {v} (Disease) Barrett's esophagus
Barrett's esophagus {u} (Disease) is treated by {v} (Compound) Omeprazole
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Pantoprazole and Pantoprazole (Compound) resembles Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Esomeprazole and Esomeprazole (Compound) resembles Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Pantoprazole and Pantoprazole (Compound) resembles Esomeprazole (Compound) and Esomeprazole (Compound) resembles Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Esomeprazole and Esomeprazole (Compound) resembles Pantoprazole (Compound) and Pantoprazole (Compound) resembles Omeprazole (Compound)
Cyanocobalamin (Compound) resembles Hydroxocobalamin (Compound) and Hydroxocobalamin (Compound) causes Agitation (Side Effect) and Agitation (Side Effect) is caused by Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Rabeprazole and Rabeprazole (Compound) resembles Esomeprazole (Compound) and Esomeprazole (Compound) resembles Omeprazole (Compound)
Cyanocobalamin (Compound) binds MUT (Gene) and MUT (Gene) is regulated by TIPARP (Gene) and TIPARP (Gene) is upregulated by Omeprazole (Compound)
Cyanocobalamin (Compound) binds TCN2 (Gene) and TCN2 (Gene) is associated with prostate cancer (Disease) and prostate cancer (Disease) is palliated by Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Pantoprazole and Pantoprazole (Compound) binds CYP1A2 (Gene) and CYP1A2 (Gene) is bound by Omeprazole (Compound)
Cyanocobalamin may cause a minor interaction that can limit clinical effects when taken with Esomeprazole and Esomeprazole (Compound) treats Barrett's esophagus (Disease) and Barrett's esophagus (Disease) is treated by Omeprazole (Compound)